Home>Topics>>NPS Pharmaceuticals ([[NPSP]] +04%) says the FDA has approved Gattex for the treatment of adult patients with short bowel syndrome who are dependent on parenteral support. The company says Gattex ...
NPS Pharmaceuticals ([[NPSP]] +04%) says the FDA has approved Gattex for the treatment of adult patients with short bowel syndrome who are dependent on parenteral support. The company says Gattex ...
NPS Pharmaceuticals (
NPSP +04% ) says the FDA has approved Gattex for the treatment of adult patients with short bowel syndrome who are dependent on parenteral support. The company says Gattex will be available in Q113. Post your comment!
Read the rest of this article on SeekingAlpha.com: SA Currents